ACADIAN ASSET MANAGEMENT LLC - TAYSHA GENE THERAPIES INC ownership

TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 53 filers reported holding TAYSHA GENE THERAPIES INC in Q4 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of TAYSHA GENE THERAPIES INC
ValueSharesWeighting
Q2 2023$46
-85.7%
70,798
-82.5%
0.00%
-100.0%
Q1 2023$321
-45.6%
405,301
+54.8%
0.00%
-66.7%
Q4 2022$590
-99.4%
261,851
+389.9%
0.00%
+200.0%
Q3 2022$102,000
-48.7%
53,4470.0%0.00%0.0%
Q2 2022$199,00053,4470.00%
Other shareholders
TAYSHA GENE THERAPIES INC shareholders Q4 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 3,827,926$12,096,2468.11%
TCG Crossover Management, LLC 11,111,111$35,111,1115.17%
VR Adviser, LLC 14,444,444$45,644,4434.80%
Kynam Capital Management, LP 3,281,313$10,368,9491.70%
Ghost Tree Capital, LLC 1,325,000$4,187,0001.38%
Octagon Capital Advisors LP 2,777,778$8,777,7781.35%
RA Capital Management 18,472,503$58,373,1091.15%
RTW INVESTMENTS, LP 16,893,185$53,382,4651.13%
Diametric Capital, LP 760,014$2,401,6441.00%
Quantum Private Wealth, LLC 575,380$1,818,2010.87%
View complete list of TAYSHA GENE THERAPIES INC shareholders